Ando, Apigyn P.
HRN: 07-94-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2022
CEFUROXIME 500MG (TAB)
04/29/2022
05/06/2022
PO
500mg
BID
Shift To Oral; Post-op Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes